Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.62B |
| Enterprise Value | 1.49B |
| P/E Ratio | -172.33 |
| PEG Ratio | -3.51 |
| Price/Sales Ratio | 1.23 |
| Price/Book Ratio | 3.42 |
| Enterprise/Revenue | -0.67 |
| Enterprise/EBITDA | 24.84 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.16 |
| Operating Margin | -0.17 |
AD
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.05 |
Income Statement
| Revenue | 685.8M |
| Revenue/Share | 0.64 |
| Gross Profit | 616.49M |
| EBITDA | -81.53M |
| Net Income | -153.36M |
| Diluted EPS | -0.14 |
Balance Sheet
| Total Cash | 1.27B |
| Total Cash/Share | 1.23 |
| Total Debt | 10.64M |
| Total Debt/Equity | 0 |
| Current Ratio | 6.15 |
| Book Value Per Share | 2.08 |
Price History
| 52-Week Change | -26.16 |
| 52-Week High | 3.69 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 2.49 |
| Moving Average 200 Days | 2.66 |
Statistics
| Average Volume | 1.17M |
| Shares Outstanding | 340M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.3 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
